Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
about
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron diseasePresymptomatic studies in ALS: rationale, challenges, and approachRisk factors for amyotrophic lateral sclerosisDifferentiating lower motor neuron syndromesAmyotrophic lateral sclerosis and motor neuron syndromes in Asia.Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.Amyotrophic lateral sclerosis presenting as upper limb weakness in a 35 year old female: a case reportThe effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study.Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia.Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California.Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011.State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditionsProjected increase in amyotrophic lateral sclerosis from 2015 to 2040Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment.Causal inference methods to study gastric tube use in amyotrophic lateral sclerosis.Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.Enteral feeding in neurological disorders.Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution.Stratification of ALS patients' survival: a population-based study.Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence.The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology.Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Associations between co-medications and survival in ALS-a cohort study from Austria.Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population.Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005).Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study.Amyotrophic lateral sclerosis in Sardinia (Italy): epidemiologic features from 1957 to 2000.MS prevalence in New Zealand, an ethnically and latitudinally diverse countryAge at onset of amyotrophic lateral sclerosis is proportional to life expectancy
P2860
Q24234807-9231CFA7-16F0-4677-AE9C-AD717DB34AF5Q26824988-557C35DC-0B96-40F2-A952-A660A0CD7F2FQ26827642-28FAD8C2-E13A-4D89-8F8E-587293F19028Q28070092-AC9D43D7-1668-468A-8857-273121482115Q30251559-07706F56-D761-4D9D-A5C6-E9B85D9A67C1Q30580165-863CC211-5FF4-48D8-B1CF-4D5C9B8316F6Q33609363-D94CA618-F978-4F81-9B1B-F94F8E3F30F6Q34159126-C0F497F0-95BD-4035-A6E0-7FCD7453483CQ35158039-44E86B1A-5C63-4784-8190-4CCB60C19583Q35404142-2D444F17-12A8-41D4-914F-21BA19001A73Q35905910-735D0359-8224-47D7-9A68-614877206B8EQ35945013-0B32C903-82E4-4E97-8DD9-D2EFAC7B8870Q35949851-53278DE2-2365-49AB-B959-4E5E93373F0FQ35982297-AE35146A-07ED-43F1-B731-2017BA3FA02CQ36003312-EE7C12D9-67B3-42D1-ADAA-70472F20C17AQ36518995-D2C8ED90-DE56-4974-B864-3B2D94557DB7Q36551001-BDE38A11-3D01-4A76-BB5B-381507266DD0Q37181233-5EE7578C-C98F-4D2A-B437-5DD5F278216FQ38055321-80624E99-9DB5-4ABE-B191-A6F38B53D4F2Q38597213-96AC6458-972D-4ED1-8D0A-BBE078BCBC8CQ38605226-268A818E-F367-42E3-9802-8D00043016ECQ38827351-903745C7-8C03-41A8-8F8A-3DB1B1198B65Q38983784-DAE07832-827A-4313-A762-961000FFEB85Q39215197-D58FE3E3-6B4B-4931-B1B8-74C041E13328Q39636560-610B08DB-91A9-41B9-B656-E8118B3F5E8AQ39863626-D384D72E-9172-424B-A64B-8BE66E232B19Q40385575-C185C636-3507-4F97-9B24-6F047FB45B8DQ40957483-671B7C41-6DAF-4FAA-95AB-CB677E80AA53Q42265210-EA0F2C9C-AE74-4761-8CC0-38FFFDD343A1Q44238273-7CA65F18-8D28-45BA-BF0E-71944591617DQ44508214-C429AFEE-9EFA-46AB-A747-E15966362AB7Q45159263-002B4D10-08AC-4EBD-9A49-E0AF76B250F4Q46820960-216DD7C3-1DE9-4CD2-A62A-E02AD739F3E6Q51166739-E4518D55-FC48-4B80-9C58-C4A4554BE5D4Q51190410-C1047437-B556-4BDA-BA9C-9571019F61A0Q57231209-CE4AADF5-0B8C-4466-91F5-4557B95B8D0DQ58125465-264764FB-C76D-4C75-9C2A-7F8B98C940BC
P2860
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@en
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@nl
type
label
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@en
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@nl
prefLabel
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@en
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@nl
P2093
P1433
P1476
Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
@en
P2093
P304
P356
10.1212/01.WNL.0000336653.65605.AC
P407
P577
2008-12-01T00:00:00Z